News:Biomarkers
Read the latest news about the use of biomarkers in research on Alzheimer's prevention.
We use artificial intelligence to validate a new biomarker of brain aging
The data have been compared with Alzheimer's biomarkers of 2,300 people from four cohorts, including participants without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation.
Biomarkers in blood lead the way to the future of Alzheimer's research
More than 80 researchers have attended the Biomarkers Workshop, a scientific event with great international impact, organised by the Barcelonaβeta Brain Research Center.
The BBRC hosts the sixth edition of the Workshop on biomarkers for neurodegenerative diseases
The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.
The validity of nine biomarkers for diagnosing Alzheimer's disease in daily clinical practice has been determined
A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.
A new study identifies two biomarkers in the blood that better capture early signs of Alzheimer's
The study, which used data from almost 400 participants of the ALFA+ Study, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms.
The project on artificial intelligence algorithms in magnetic resonance obtains a 'Digital EIT 2021'
The organization under the European Commission will finance part of the project
Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease
The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor
BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020
The most prominent congress dedicated to Alzheimer's research has been held completely virtual
Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women
The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy
